ロード中...
Continuous glucose monitoring in youth with cystic fibrosis treated with lumacaftor-ivacaftor
BACKGROUND: The effects of lumacaftor-ivacaftor therapy on glycemia have not been thoroughly investigated. Continuous glucose monitoring (CGM) provides detailed information about glycemic patterns and detects glucose abnormalities earlier than traditional screening tools for diabetes. METHODS: CGM m...
保存先:
| 出版年: | J Cyst Fibros |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6342629/ https://ncbi.nlm.nih.gov/pubmed/30104123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2018.07.010 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|